Related Experiment Videos
Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments
1Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, Chinese University of Hong Kong, Shatin, Hong Kong. qtao@clo.cuhk.edu.hk
Expert Reviews in Molecular Medicine
|May 5, 2007
Summary
Nasopharyngeal carcinoma (NPC) is a complex cancer influenced by genetics, Epstein-Barr virus (EBV), and carcinogens. New biomarkers and therapies offer improved diagnosis and treatment for this prevalent tumor.
Area of Science:
- Oncology
- Virology
- Genetics
Background:
- Nasopharyngeal carcinoma (NPC) is a significant health concern in Southern China and Southeast Asia.
- NPC's etiology is multifactorial, involving genetic predisposition, Epstein-Barr virus (EBV) infection, and environmental carcinogen exposure.
- The synergistic interplay of viral factors and genetic/epigenetic alterations drives NPC pathogenesis.
Purpose of the Study:
- To review the complex etiology of Nasopharyngeal Carcinoma (NPC).
- To highlight advancements in molecular diagnosis and novel therapeutic strategies for NPC.
- To discuss the challenges in treating locoregionally advanced NPC.
Main Methods:
- Literature review of recent studies on NPC etiology, diagnosis, and treatment.
- Analysis of genetic, viral, and environmental factors contributing to NPC.
- Evaluation of emerging diagnostic biomarkers and therapeutic modalities.
Main Results:
- NPC development involves a complex interplay of genetic susceptibility, EBV infection, and chemical carcinogens.
- Novel biomarkers like EBV DNA and gene methylation in serum/brushings aid molecular diagnosis.
- Advanced treatments including intensity-modulated radiation therapy and immuno-epigenetic therapies show promise.
Conclusions:
- Understanding NPC's complex etiology is crucial for effective management.
- Emerging biomarkers enhance early and accurate molecular diagnosis of NPC.
- New therapeutic strategies offer potential for more targeted and effective NPC treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...